Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Oral forodesine (Bcx-1777) is clinically active in refractory cutaneous T-cell lymphoma: Results of a phase I/II study. Duvic, M., Forero-Torres, A., Foss, F., Olsen, E. A., Kim, Y. AMER SOC HEMATOLOGY. 2006: 698A
View details for Web of Science ID 000242440003257